Melanoma, Skin cancer
Results
Phase 2
This trial looked at a drug called selumetinib alongside dacarbazine for people with melanoma that has spread to another part of the body. This is called advanced melanoma.
The trial was for people whose melanoma cells have a change () in a called BRAF.
Recruitment start: 20 July 2009
Recruitment end: 8 April 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Mark Middleton
AstraZeneca
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Last reviewed: 6 May 2015
CRUK internal database number: 5289
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
